KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for Elanco Animal Health (ELAN) over the last 8 years, with Q3 2025 value amounting to $4.0 billion.

  • Elanco Animal Health's Non-Current Debt fell 813.82% to $4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 813.82%. This contributed to the annual value of $4.3 billion for FY2024, which is 2543.58% down from last year.
  • Per Elanco Animal Health's latest filing, its Non-Current Debt stood at $4.0 billion for Q3 2025, which was down 813.82% from $4.1 billion recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Non-Current Debt registered a high of $6.3 billion during Q3 2021, and its lowest value of $4.0 billion during Q3 2025.
  • Moreover, its 5-year median value for Non-Current Debt was $5.6 billion (2021), whereas its average is $5.4 billion.
  • As far as peak fluctuations go, Elanco Animal Health's Non-Current Debt surged by 17295.11% in 2021, and later tumbled by 2652.47% in 2024.
  • Over the past 5 years, Elanco Animal Health's Non-Current Debt (Quarter) stood at $6.0 billion in 2021, then decreased by 9.58% to $5.4 billion in 2022, then rose by 5.29% to $5.7 billion in 2023, then dropped by 25.44% to $4.3 billion in 2024, then decreased by 7.36% to $4.0 billion in 2025.
  • Its last three reported values are $4.0 billion in Q3 2025, $4.1 billion for Q2 2025, and $4.4 billion during Q1 2025.